Simplex Trading, LLC Avrobio, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$0.76 - $1.82 $551 - $1,319	725 New	725 $0
Q2 2022 Aug 03, 2022	SELL	$0.75 - $1.33 $1,425 - $2,527	-1,900 Reduced 88.54%	246 $0
Q1 2022 May 02, 2022	BUY	$1.29 - $4.04 $2,768 - $8,669	2,146 New	2,146 $2,000
Q2 2021 Aug 12, 2021	SELL	$7.84 - $12.6 $44,742 - $71,908	-5,707 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$10.54 - $19.3 $53,701 - $98,333	5,095 Added 832.52%	5,707 $72,000
Q4 2020 Feb 02, 2021	BUY	$12.79 - $17.1 $920 - $1,231	72 Added 13.33%	612 $8,000
Q3 2020 Oct 14, 2020	BUY	$12.99 - $19.41 $7,014 - $10,481	540 New	540 $7,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.